Ainos (AIMDW) Competitors $0.12 +0.02 (+19.30%) As of 03/28/2025 01:09 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsTrendsBuy This Stock AIMDW vs. ATNFW, LBPSW, AARD, AEHAW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, and CELUWShould you be buying Ainos stock or one of its competitors? The main competitors of Ainos include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aardvark Therapeutics (AARD), Aesther Healthcare Acquisition (AEHAW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry. Ainos vs. 180 Life Sciences 4D pharma Aardvark Therapeutics Aesther Healthcare Acquisition Alvotech Atlantic Coastal Acquisition Corp. II Biofrontera biote BriaCell Therapeutics Celularity Ainos (NASDAQ:AIMDW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, dividends, valuation, community ranking, risk, analyst recommendations, media sentiment, earnings and profitability. Does the media refer more to AIMDW or ATNFW? In the previous week, Ainos and Ainos both had 1 articles in the media. 180 Life Sciences' average media sentiment score of 1.89 beat Ainos' score of 1.87 indicating that 180 Life Sciences is being referred to more favorably in the news media. Company Overall Sentiment Ainos Very Positive 180 Life Sciences Very Positive Which has better earnings & valuation, AIMDW or ATNFW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAinos$20.73KN/AN/AN/AN/A180 Life SciencesN/AN/AN/AN/AN/A Is AIMDW or ATNFW more profitable? Company Net Margins Return on Equity Return on Assets AinosN/A N/A N/A 180 Life Sciences N/A N/A N/A Does the MarketBeat Community favor AIMDW or ATNFW? Ainos and 180 Life Sciences both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformAinosN/AN/A180 Life SciencesN/AN/A SummaryAinos and 180 Life Sciences tied by winning 1 of the 2 factors compared between the two stocks. Remove Ads Get Ainos News Delivered to You Automatically Sign up to receive the latest news and ratings for AIMDW and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AIMDW vs. The Competition Export to ExcelMetricAinosMedical Devices IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$3.55B$5.63B$7.84BDividend YieldN/A2.44%5.33%4.01%P/E RatioN/A79.2323.6018.74Price / SalesN/A130.76388.2390.77Price / CashN/A15.9938.1734.64Price / BookN/A3.806.894.23Net IncomeN/A$126.02M$3.20B$247.47M7 Day Performance-29.68%-3.60%-3.06%-2.29%1 Month Performance-45.50%-6.79%1.52%-5.81%1 Year PerformanceN/A-12.26%9.37%-0.96% Ainos Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AIMDWAinosN/A$0.12+19.3%N/A+86.5%$0.00$20,729.000.0040Positive NewsGap DownATNFW180 Life SciencesN/A$0.01-3.4%N/A-7.3%$0.00N/A0.007Gap DownLBPSW4D pharmaN/AN/AN/AN/A$0.00$522,000.000.00N/AAARDAardvark TherapeuticsN/A$9.42+1.7%$30.50+223.8%N/A$0.00N/A0.0018Analyst ForecastQuiet Period ExpirationNews CoverageGap DownAEHAWAesther Healthcare AcquisitionN/A$0.03+0.4%N/A-92.1%$0.00N/A0.002ALVOWAlvotechN/A$1.86+0.5%N/A-52.7%$0.00$391.87M0.004Short Interest ↓News CoverageGap DownACABWAtlantic Coastal Acquisition Corp. IIN/A$0.05flatN/AN/A$0.00N/A0.004BFRIWBiofronteraN/A$0.06-20.0%N/AN/A$0.00$35.36M0.0070Gap UpBTMDWbioteN/A$0.07-1.5%N/A-88.1%$0.00$197.19M0.00N/ABCTXWBriaCell TherapeuticsN/A$0.09-7.4%N/A-93.1%$0.00N/A0.008Short Interest ↓News CoverageGap UpCELUWCelularityN/A$0.06-0.2%N/A+14.1%$0.00$48.20M0.00220Positive News Remove Ads Related Companies and Tools Related Companies 180 Life Sciences Competitors 4D pharma Competitors Aardvark Therapeutics Competitors Aesther Healthcare Acquisition Competitors Alvotech Competitors Atlantic Coastal Acquisition Corp. II Competitors Biofrontera Competitors biote Competitors BriaCell Therapeutics Competitors Celularity Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AIMDW) was last updated on 3/30/2025 by MarketBeat.com Staff From Our PartnersTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | SponsoredNvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry."If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredTrump doesn’t give a damnPorter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met...Porter & Company | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredWall Street’s “AI Oracle” Reveals Next Big Tech PlayA tiny American tech company could be at the center of the next big AI breakthrough. Wall Street's "AI Orac...InvestorPlace | SponsoredElon’s ‘Strike Squad’ sends these 9 stocks soaring?Elon Musk's DOGE 'strike squad' just revealed it's speeding up the rollout of a radical technology across the ...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ainos, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ainos With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
